Rafail A. Kotronias: Improving the Detection and Management of Coronary Microvascular Obstruction
Rafail A. Kotronias, Clinical Trials Fellow at Acute Multidisciplinary Imaging and Interventional Centre (AMIIC), University of Oxford shared a post on LinkedIn about recent articles, adding:
”A particularly rewarding milestone from my University of Oxford DPhil
Two of my research outputs are referenced in the new European Society of Cardiology clinical consensus statement on coronary microvascular obstruction (MVO) ‘Pathophysiology, prevention, and management of coronary microvascular obstruction’
The two pieces represent different but complementary aspects of my DPhil work: A novel approach to evaluating MVO with photon-counting CT – developing new ways to reliably and rapidly characterise this important injury component.
A clinical device trial designed to address large thrombus burden; a contributor to MVO – translating our understanding of the problem into an intervention aimed at improving it.
A gratifying reminder of why we do clinical research: to move from understanding a problem, to measuring it better, to finding ways to improve outcomes for patients.
Very grateful to all the collaborators Siemens Healthineers, Medtronic, supervisors Charalambos Antoniades, Giovanni Luigi De Maria, Keith Channon, mentors and Oxford University Hospitals NHS Foundation Trust patients who made this work possible.”
1. Title: Pathophysiology, prevention, and management of coronary microvascular obstruction: A clinical consensus statement of the ESC Working Group on Coronary Pathophysiology & Microcirculation, the ESC Working Group on Thrombosis, and the European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC
Authors: Edina Cenko , Lina Badimon , Giuseppe Vadalà , Daphne Merkus , Charalambos Antoniades , Carlos Collet , Giovanni Luigi De Maria, Ana Djordjevic-Dikic, Ines Drenjancevic, Javier Escaned, José Luis Ferreiro, Ingrid Fleming, Tomasz Guzik, Olivia Manfrini, Davor Milicic, Teresa Padro , Italo Porto, Laurent Marc Riou, Nicola Ryan, Dimitris Tousoulis, Heleen M M van Beusekom, Marija Vavlukis, Gemma Vilahur, Marija Zdravkovic, Dirk J Duncker, Alfredo Ruggero Galassi, Raffaele Bugiardini
Read the Full Article on European Heart Journal
2.Title: Evaluating Acute Ischemic Myocardial Injury With Photon-Counting Computed Tomography
Authors: : Rafail A. Kotronias, Leonardo Portolan, Cheng Xie, Vanessa M. Ferreira, Betty Raman, Ernst Klotz, Giovanni L. De Maria, Ron Blankstein, Keith M. Channon, Stefan Neubauer, and Charalambos Antoniades
Read the Full Article on JACC: Cardiovascular Imaging
3.Title: Stent-Retriever Thrombectomy in STEMI With Large Thrombus Burden: The RETRIEVE AMI Randomized Trial
Authors: Rafail A. Kotronias, JasonL. Walsh, Stefano Andreaggi, Leonardo Portolan, Alessandro Maino, Federico Marin, Jason Chai, Ikboljon Sobirov, Muhammad Sheikh, Thomas J. Cahill, Andrew J. Lucking, Max Costello, Eva Fraile Moreno, Vrinda Haridas, Anisha Shaji, Hector M. Garcia-Garcia, Keith M. Channon, Adrian P. Banning, Jeremy P. Langrish, and Giovanni Luigi De Maria
Read the Full Article on JACC:Advances
Stay updated on the latest scientific advances with Hemostasis Today.
-
Aug 20, 2026, 15:15The Cell in Your Bone Marrow Responsible for Making Platelets – ITP Support Association
-
Aug 20, 2026, 15:10Shiny K. Kajal: The Latest ISBT Blood Group Update Is Here
-
Aug 20, 2026, 14:57Spiros Denaxas: The Risk Factor Paradox in Recurrent Heart Disease
-
Aug 20, 2026, 14:44ISTH SSC Women’s Health Survey: Thromboprophylaxis in Pregnancy
-
Aug 20, 2026, 14:22Wolfgang Miesbach։ Thrombosis After Haemophilia B Gene Therapy
-
Aug 20, 2026, 14:08Ahmed Mostafa: Decoding HLA-B27 in Ankylosing Spondylitis
-
Aug 20, 2026, 14:00Cindy Neunert: What Matters Most to Patients with ITP
-
Aug 20, 2026, 13:46Mario Enrico Canonico։ CLEAR Outcomes Analysis Highlights Bempedoic Acid Benefits in PAD
-
Aug 20, 2026, 13:34Ons Marsit: What Is the Residual Thromboembolic Risk After AF Ablation?